Obesidad y Diabetes Mellitus tipo II: manejo clínico y farmacológico

Abstract

Introduction: according to the WHO, overweight and obesity are of concern due to their association with unhealthy habits, lack of physical activity and unhealthy diet, diet—factors contributing to their association. Type 2 Diabetes Mellitus (DM2) is a common consequence of obesity, and its increasing prevalence worldwide raises the necessity to address both obesity prevention and comprehensive diabetes management to reduce its impact on public health. Objective: To describe the efficacy of clinical and pharmacological management in controlling DM2 in patients with obesity. Methodology: A literature review was conducted to compile and analyze relevant studies on the clinical and pharmacological management of obesity and Type II Diabetes Mellitus. After an exhaustive search in multiple databases and applying inclusion and exclusion criteria, 12 articles were selected from an initial total of 368 references that met the necessary requirements for this literature review. Expected Results: It was demonstrated that controlling and improving blood glucose levels, reducing Body Mass Index (BMI) by incorporating a healthy lifestyle, and educating patients to prevent disease-related complications, combined with pharmacological therapy, is effective in controlling DM2 in patients with obesity. Keywords: Hypoglycemic Agents, Type 2 Diabetes Mellitus, Healthy Lifestyle, Obesity, Non-Pharmacological Therapies.